Aap Implantate AG Stock
Price
Target price
€1.38
€1.38
-6.120%
-0.09
-6.120%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Aap Implantate AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Aap Implantate
sharewise wants to provide you with the best news and tools for Aap Implantate, so we directly link to the best financial data sources.
Financials
News

EQS-News: aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region
EQS-News: aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region

EQS-Adhoc: aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024
EQS-Adhoc: aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024

EQS-News: Announcement of an audit order by BaFin
EQS-News: Announcement of an audit order by BaFin

EQS-News: Progress in the MDR process - aap receives MDR certificate
EQS-News: Progress in the MDR process - aap receives MDR certificate

EQS-News: Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)
EQS-News: Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)